Azenta, Inc. (LON:0HQ1)
25.40
-0.33 (-1.26%)
At close: Apr 17, 2025
Azenta Revenue
Azenta had revenue of $147.51M USD in the quarter ending December 31, 2024, with 4.08% growth. This brings the company's revenue in the last twelve months to $662.11M, up 5.36% year-over-year. In the fiscal year ending September 30, 2024, Azenta had annual revenue of $656.32M, down -1.32%.
Revenue (ttm)
$662.11M
Revenue Growth
+5.36%
P/S Ratio
1.68
Revenue / Employee
$200.64K
Employees
3,300
Market Cap
887.59M GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Sep 30, 2024 | 656.32M | -8.75M | -1.32% |
Sep 30, 2023 | 665.07M | 109.57M | 19.73% |
Sep 30, 2022 | 555.50M | 41.80M | 8.14% |
Sep 30, 2021 | 513.70M | 125.17M | 32.21% |
Sep 30, 2020 | 388.54M | 54.36M | 16.27% |
Sep 30, 2019 | Pro | Pro | Pro |
Sep 30, 2018 | Pro | Pro | Pro |
Sep 30, 2017 | Pro | Pro | Pro |
Sep 30, 2016 | Pro | Pro | Pro |
Sep 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 43.19B |
GSK plc | 31.38B |
Haleon | 11.23B |
Smith & Nephew | 4.64B |
ConvaTec Group | 1.83B |
Hikma Pharmaceuticals | 2.50B |
HUTCHMED (China) | 503.39M |
Oxford Nanopore Technologies | 183.19M |
Azenta News
- 4 weeks ago - Azenta Publishes its 2024 Environmental, Social, & Governance (ESG) Report - PRNewsWire
- 6 weeks ago - Azenta to Participate in the Virtual KeyBanc Capital Markets Healthcare Forum - PRNewsWire
- 2 months ago - Azenta Inc (AZTA) Trading Down 5.56% on Feb 27 - GuruFocus
- 2 months ago - Azenta Inc (AZTA) Shares Down 4.06% on Feb 11 - GuruFocus
- 2 months ago - Azenta, Inc. 2025 Q1 - Results - Earnings Call Presentation - Seeking Alpha
- 2 months ago - Azenta reiterates 2025 guidance with 3-5% organic growth and EBITDA margin expansion - Seeking Alpha
- 2 months ago - Azenta, Inc. (AZTA) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Azenta beats Q1 top-line and bottom-line estimates; reaffirms FY25 outlook - Seeking Alpha